Cardiology
Conference Coverage
Allopurinol and ventricular arrhythmias: Is there a link?
MADRID – The gout drug’s tie to fewer arrhythmias strengthened over time.
Conference Coverage
Optimal age for cardiovascular disease screening remains elusive
SAN FRANCISCO – What level of cardiovascular risk should prompt the use of statins for primary prevention?
Conference Coverage
VIDEO: Cardiovascular events in rheumatoid arthritis have decreased over decades
MADRID – Since 2000, the risk ratios for several CV events have declined.
Conference Coverage
Lithoplasty tames heavily calcified coronary lesions
PARIS – Novel pre-PCI “lithotripsy inside a balloon” technology is also approved for PAD.
Conference Coverage
Amplatzer devices outperform oral anticoagulation in atrial fib
PARIS – Greater net clinical benefit documented in registry.
Conference Coverage
Do sleep interventions prevent atrial fibrillation?
WASHINGTON – Obstructive sleep apnea treatment may not fend off arrhythmias in patients with cardiovascular disease.
From the Journals
Herpes zoster raises risk of stroke, MI
Several mechanisms of action are offered.
PURLs
Which combined OC to prescribe with CV safety in mind?
With various formulations available, which combined OC should you recommend to minimize not only the risk of PE, but also the risk of stroke and...
Applied Evidence
Stroke: Secondary prevention of ischemic events
A multifactorial approach is key to effective secondary stroke prevention. Here’s how to individualize your plan for your at-risk patients.
Conference Coverage
LEADER post hoc analysis: Mechanism behind liraglutide’s cardioprotective effects unclear
SAN DIEGO – The glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide significantly reduced the risk of initial and recurrent major...
From the Journals
Childhood asthma linked to high LV mass later
A history of childhood asthma correlates with high left ventricular mass, a prominent indicator of cardiac damage, in asymptomatic healthy young...